Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kasper

Showing results (171-180 of 497) with videos related to

Pageof 50
Sort By:
Archives of Dermatology|August 1, 1987
Diagnosis of mastocytosis subsets using a morphometric point counting techniqueC S Kasper, R G Freeman, M D Tharp
Der Nervenarzt|December 31, 1997
[Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches]E Lenzinger, K Diamant, E Vytiska-Binstorfer, et al.
Drug Safety|November 14, 1997
A risk-benefit assessment of mirtazapine in the treatment of depressionS Kasper, N Praschak-Rieder, J Tauscher, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Evidence for a seasonal form of recurrent brief depression (RBD-seasonal)S Kasper, S Ruhrmann, T Haase, et al.
The American Journal of Psychiatry|August 1, 1995
Trigeminal neuralgic syndrome after bright light therapyS Schindler, C Barnas, H Leitner, et al.
Der Nervenarzt|March 1, 1994
[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease]G Höflich, K W Burghof, S Kasper, et al.
Lancet (London, England)|September 6, 1980
Arthropathies and schizophreniaW F Gattaz, S Kasper, R W Ewald, et al.
International Clinical Psychopharmacology|August 23, 2000
Occurrence of mirtazapine-induced delirium in organic brain disorderU Bailer, P Fischer, B Küfferle, et al.
International Clinical Psychopharmacology|January 1, 1995
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramineS Kasper, H J Möller, S A Montgomery, et al.
MMW Fortschritte Der Medizin|January 17, 2002
[General practice research study of St. Johns Wort extract WS 5572. Normally 600 mg per day is enough]R Rychlik, H Siedentop, V von den Driesch, et al.
Pageof 50

Showing results (171-180 of 497) with videos related to

Sort By:
Pageof 50
Archives of Dermatology|August 1, 1987
Diagnosis of mastocytosis subsets using a morphometric point counting techniqueC S Kasper, R G Freeman, M D Tharp
Der Nervenarzt|December 31, 1997
[Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches]E Lenzinger, K Diamant, E Vytiska-Binstorfer, et al.
Drug Safety|November 14, 1997
A risk-benefit assessment of mirtazapine in the treatment of depressionS Kasper, N Praschak-Rieder, J Tauscher, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Evidence for a seasonal form of recurrent brief depression (RBD-seasonal)S Kasper, S Ruhrmann, T Haase, et al.
The American Journal of Psychiatry|August 1, 1995
Trigeminal neuralgic syndrome after bright light therapyS Schindler, C Barnas, H Leitner, et al.
Der Nervenarzt|March 1, 1994
[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease]G Höflich, K W Burghof, S Kasper, et al.
Lancet (London, England)|September 6, 1980
Arthropathies and schizophreniaW F Gattaz, S Kasper, R W Ewald, et al.
International Clinical Psychopharmacology|August 23, 2000
Occurrence of mirtazapine-induced delirium in organic brain disorderU Bailer, P Fischer, B Küfferle, et al.
International Clinical Psychopharmacology|January 1, 1995
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramineS Kasper, H J Möller, S A Montgomery, et al.
MMW Fortschritte Der Medizin|January 17, 2002
[General practice research study of St. Johns Wort extract WS 5572. Normally 600 mg per day is enough]R Rychlik, H Siedentop, V von den Driesch, et al.
Pageof 50